Key facts
- This page summarizes Diana Brainard's Form 4 filing for Allovir, Inc. (KLRS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 20 Nov 2024, 16:15.
Diana Brainard - 19 Nov 2024 Form 4 Insider Report for Allovir, Inc. (KLRS)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- KLRS
- Reported as of
- 19 Nov 2024
- Net transaction value
- -$4,775
- SEC form
- 4
- Accepted by SEC
- 20 Nov 2024, 16:15:03 UTC
- Prior SEC filing
- 06 Nov 2024
- Next SEC filing
- 17 Jan 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brett Hagen, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Diana Brainard filed Form 4 for Allovir, Inc. (KLRS) on 20 Nov 2024.
Change
- Previous filing in this sequence was filed on 06 Nov 2024.
- Current net transaction value: -$4,775.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALVR
transaction
Common Stock
Sale
- Transaction value
- $4,775
- Shares
- -8,706
- Change %
- -1.2%
- Price
- $0.5485
- Shares after
- 723,363
- Date
- 19 Nov 2024
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
Footnote F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.545 to $0.572. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.